Diagnostics For All Inc:企業の製品パイプライン分析

◆英語タイトル:Diagnostics For All Inc - Product Pipeline Analysis, 2020 Update
◆商品コード:GDME258740PD
◆発行会社(調査会社):GlobalData
◆発行日:2021年1月
◆ページ数:32
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD1,500 ⇒換算¥162,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD2,250 ⇒換算¥243,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Diagnostics For All Inc (DFA) is a drug development company that develops and commercializes of new technology and practical diagnostic devices for diagnostic companies. The company uses patterned paper technology to create electrochemical clinical chemistry assays, immunoassays, assays, and molecular diagnostics. Its patterned paper technology delivers diagnostic devices to support animal and human health. DFA operates projects on small farmer support, nucleic acid detection, liver function, child nutrition, and immunity, among others. The company also develops nucleic acid amplification and immunoassay based paper microfluidic devices. Its small farmer support project develops diagnostics such as milk spoilage and bovine heat detection. DFA is headquartered in Salem, Massachusetts, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Diagnostics For All Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Diagnostics For All Inc Company Overview
Diagnostics For All Inc Company Snapshot
Diagnostics For All Inc Pipeline Products and Ongoing Clinical Trials Overview
Diagnostics For All Inc – Pipeline Analysis Overview
Diagnostics For All Inc – Key Facts
Diagnostics For All Inc – Major Products and Services
Diagnostics For All Inc Pipeline Products by Development Stage
Diagnostics For All Inc Pipeline Products Overview
Paper-Based Diagnostic Device – Anemia
Paper-Based Diagnostic Device – Anemia Product Overview
Paper-Based Diagnostic Device – Hypertensive Disorders
Paper-Based Diagnostic Device – Hypertensive Disorders Product Overview
Paper-Based Microfluidic Device – Brucella Abortus
Paper-Based Microfluidic Device – Brucella Abortus Product Overview
Paper-Based Microfluidic Device – Ebola
Paper-Based Microfluidic Device – Ebola Product Overview
Paper-Based Microfluidic Device – Hepatitis B
Paper-Based Microfluidic Device – Hepatitis B Product Overview
Paper-Based Microfluidic Device – Hepatitis C
Paper-Based Microfluidic Device – Hepatitis C Product Overview
Paper-Based Microfluidic Device – HIV
Paper-Based Microfluidic Device – HIV Product Overview
Paper-Based Microfluidic Test – Syphilis
Paper-Based Microfluidic Test – Syphilis Product Overview
Point-Of-Care Diagnostic Assay – Immunity Assessment
Point-Of-Care Diagnostic Assay – Immunity Assessment Product Overview
Point-Of-Care Diagnostic Device – Diabetes
Point-Of-Care Diagnostic Device – Diabetes Product Overview
Point-Of-Care Diagnostic Device – Malaria
Point-Of-Care Diagnostic Device – Malaria Product Overview
Diagnostics For All Inc – Key Competitors
Diagnostics For All Inc – Key Employees
Diagnostics For All Inc – Locations And Subsidiaries
Head Office
Recent Developments
Diagnostics For All Inc, Recent Developments
Jul 22, 2015: DFA Scientist Receives Seed Grant To Develop Diagnostic Test for Hepatitis B
Jul 22, 2015: DFA Scientist Receives Seed Grant To Develop Diagnostic Test for Syphilis
Jan 26, 2015: Diagnostics For All Appoints Fran Heller, Former Bristol-Myers Squibb Senior Executive, to Board of Directors
Dec 16, 2014: Governor Patrick, Massachusetts Life Sciences Center Announce $1 Million Grant to Fund Research and Development of Ebola Diagnostic Test
Sep 19, 2012: BIDMC And DFA Create First Low-Cost, Paper-Based, Point Of Care Liver Function Test
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
Diagnostics For All Inc Pipeline Products and Ongoing Clinical Trials Overview
Diagnostics For All Inc Pipeline Products by Equipment Type
Diagnostics For All Inc Pipeline Products by Indication
Diagnostics For All Inc, Key Facts
Diagnostics For All Inc, Major Products and Services
Diagnostics For All Inc Number of Pipeline Products by Development Stage
Diagnostics For All Inc Pipeline Products Summary by Development Stage
Paper-Based Diagnostic Device - Anemia - Product Status
Paper-Based Diagnostic Device - Anemia - Product Description
Paper-Based Diagnostic Device - Hypertensive Disorders - Product Status
Paper-Based Diagnostic Device - Hypertensive Disorders - Product Description
Paper-Based Microfluidic Device - Brucella Abortus - Product Status
Paper-Based Microfluidic Device - Brucella Abortus - Product Description
Paper-Based Microfluidic Device - Ebola - Product Status
Paper-Based Microfluidic Device - Ebola - Product Description
Paper-Based Microfluidic Device - Hepatitis B - Product Status
Paper-Based Microfluidic Device - Hepatitis B - Product Description
Paper-Based Microfluidic Device - Hepatitis C - Product Status
Paper-Based Microfluidic Device - Hepatitis C - Product Description
Paper-Based Microfluidic Device - HIV - Product Status
Paper-Based Microfluidic Device - HIV - Product Description
Paper-Based Microfluidic Test - Syphilis - Product Status
Paper-Based Microfluidic Test - Syphilis - Product Description
Point-Of-Care Diagnostic Assay - Immunity Assessment - Product Status
Point-Of-Care Diagnostic Assay - Immunity Assessment - Product Description
Point-Of-Care Diagnostic Device - Diabetes - Product Status
Point-Of-Care Diagnostic Device - Diabetes - Product Description
Point-Of-Care Diagnostic Device - Malaria - Product Status
Point-Of-Care Diagnostic Device - Malaria - Product Description
Diagnostics For All Inc, Key Employees
Glossary

★海外企業調査レポート[Diagnostics For All Inc:企業の製品パイプライン分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Duke Energy Carolinas LLC:企業の戦略的SWOT分析
    Duke Energy Carolinas LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • SQI Diagnostics Inc (SQD):企業の財務・戦略的SWOT分析
    Summary SQI Diagnostics Inc (SQI Diagnostics) is a diagnostic company that provides in vitro diagnostic and pharmaceutical research products. It provides products such as sqidworks, sqidlite and sqid-X. Its sqidworks system is used in labs. SQI Diagnostic’s sqidlite is a practical benchtop system. I …
  • Rubis SCA (RUI):企業の財務・戦略的SWOT分析
    Rubis SCA (RUI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Mercachem Holding bv:製薬・医療:M&Aディール及び事業提携情報
    Summary Mercachem Holding BV (Mercachem) is a research company that offers transparent chemistry services. The company provides services in the areas of discovery chemistry, medicinal chemistry, parallel chemistry and process research. Its parallel chemistry services include library design, chemical …
  • Shine Medical Technologies Inc:医療機器:M&Aディール及び事業提携情報
    Summary Shine Medical Technologies Inc (Shine Medical) is a manufacturer and supplier of medical tracers and cancer treatment elements. The company’s products include molybdenum-99 is the parent isotope of technetium 99m for diagnosing and staging multitude of diseases, including cancer and heart di …
  • BioFactura Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary BioFactura Inc (Biofactura) is a manufacturer of biosimilars that discovers, develops and markets biodefense drugs and client selected novel drugs. The company provides contract services such as process development, stable cell lines, manufacturing, and others. Its stable cell line offers st …
  • Brookfield Property REIT Inc (GGP):企業の財務・戦略的SWOT分析
    Brookfield Property REIT Inc (GGP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Transaero, Inc.:企業の戦略・SWOT・財務情報
    Transaero, Inc. - Strategy, SWOT and Corporate Finance Report Summary Transaero, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Mangalore Refinery and Petrochemicals Ltd (MRPL):企業の財務・戦略的SWOT分析
    Mangalore Refinery and Petrochemicals Ltd (MRPL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key s …
  • TECSYS Inc. (TCS):企業の財務・戦略的SWOT分析
    TECSYS Inc. (TCS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • StageZero Life Sciences Ltd (GEN):企業の財務・戦略的SWOT分析
    Summary StageZero Life Sciences Ltd (StageZero Life Sciences) is a provider of molecular diagnostic products. The company develops and commercializes diagnostics and personalized medicine for cancer and other chronic diseases. Its Sentinel Principle is a novel approach to identifying biomarkers of b …
  • Concardis Gmbh:企業の戦略・SWOT・財務分析
    Concardis Gmbh - Strategy, SWOT and Corporate Finance Report Summary Concardis Gmbh - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Cohu Inc (COHU):企業の財務・戦略的SWOT分析
    Cohu Inc (COHU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • MaaT Pharma-製薬・医療分野:企業M&A・提携分析
    Summary MaaT Pharma (MaaT) is a biotechchnology company that develop novel treatments for Gut Microbiota - dysbiosis related diseases. The company is working on two projects, which are in the developmental stage, namely, MaaT001, an innovative live frozen inoculum suspension and MaaT002, an innovati …
  • Lietuvos energijos gamyba, AB (LNR1L):企業の財務・戦略的SWOT分析
    Lietuvos energijos gamyba, AB (LNR1L) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Theravance Biopharma Inc (TBPH):企業の財務・戦略的SWOT分析
    Theravance Biopharma Inc (TBPH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Albireo Pharma Inc (ALBO)-製薬・医療分野:企業M&A・提携分析
    Summary Albireo Pharma Inc (Albireo), formerly Biodel Inc., is a specialty biopharmaceutical company that focuses on the development and commercialization of innovative bile acid modulators for the treatment of orphan pediatric liver diseases and other liver and gastrointestinal (GI) disorders and d …
  • Actelion Pharmaceuticals Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Actelion Pharmaceuticals Ltd (Actelion), subsidiary of Johnson & Johnson is a biopharmaceutical company, which discovers, develops and commercializes innovative treatments for diseases with considerable unmet medical needs. The company focuses on the development of treatments for pulmonary a …
  • Globe Telecom, Inc.:企業の戦略・SWOT・財務分析
    Globe Telecom, Inc. - Strategy, SWOT and Corporate Finance Report Summary Globe Telecom, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Gland Pharma Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Gland Pharma Ltd (Gland Pharma) is a healthcare products provider that develops and manufactures active pharmaceutical ingredients. The company’s products include injectables, pre filled syringes, vials, ampoules, infusions, ophthalmic solutions, lyophilized vials, dry powders, lyophilized p …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆